People · Operator
Named in public records as an officer, director or promoter · active 2015–2019 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | — | Biotechnology | Series C | $94.5M | $3.9B | 2019 |
| Karan Therapeutics, Inc. | — | Biotechnology | Pre-Seed | $105K | $5.8M | 2015 |
Todd Franklin Watanabe at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Todd Franklin Watanabe on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Alexander Franklin Asam | 1 | 1 |
| Patrick Franklin Heron | 1 | 1 |
| Daniel Franklin Estes | 1 | 1 |
| Ricky Franklin Sun | 1 | 1 |
| Jonathan Franklin Silverstein | 1 | 1 |
| Bhaskar Franklin Chaudhuri | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.